Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2010
01/14/2010WO2010004197A2 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
01/14/2010WO2010003624A2 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
01/14/2010WO2010003614A2 Transfection solution
01/14/2010WO2009132453A8 Cyclylamine derivatives as calcium channel blockers
01/14/2010US20100010189 Gas-phase process for the synthesis of diaminopyridines from glutaronitriles
01/14/2010US20100010063 Heterocyclocarboxamide derivatives
01/14/2010US20100010012 Glutamate aggrecanase inhibitors
01/14/2010US20100010004 Inhibitors of histone deacetylase
01/14/2010US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
01/14/2010CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof
01/14/2010CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof
01/13/2010EP2142511A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
01/13/2010EP2142507A1 Process for the preparation of sorafenib and salts thereof
01/13/2010EP1924558B1 An antimalarial baylis-hillman adducts and a process for the preparation thereof
01/13/2010EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions
01/13/2010EP1465886B1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
01/13/2010EP1144388B1 Acyl derivatives which treat vla-4 related disorders
01/13/2010CN101624370A Polymolybdate compounds and method of preparing same
01/13/2010CN101624369A Aromatic heterocyclic substituted salicylaldehyde derivatives and preparation method thereof
01/13/2010CN100579965C Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting N-aryl carbamate with halo-heteroaryl and analogous processes
01/13/2010CN100579964C Method for producing weedicide clopyralid
01/13/2010CN100579957C Novel arylamidine derivative or salt thereof
01/13/2010CN100579956C Insecticidal antibacterial sulphur, oxygen and oxime-containing ether compounds
01/12/2010US7645903 immunoglobulins; affinity chromatography
01/12/2010US7645805 a core which is functionalized with three amino acid derived groups by means of an amide or urea linkage. It may be used to gelate or thicken numerous solvents
01/12/2010US7645799 thromboembolic and/or inflammatory disorders; 4-Aminomethyl-cyclohexanecarboxylic acid (1-biphenyl-3-yl-2-phenyl-ethyl)-amide; selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; improved pharmacological properties, plasma kallikrein activity
01/12/2010US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
01/12/2010US7645780 N-[(1S,2R)-3-{[1-(3-bromophenyl)cyclopropyl]amino}-1-(3,5-difluorobenzyl)-2-hydroxypropyl]acetamide hydrochloride; for Alzheimer's disease; inhibitors of beta-secretase
01/12/2010US7645779 Linked biaryl compounds
01/12/2010US7645770 Phenylalanine enamide derivatives
01/12/2010US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
01/12/2010US7645434 Ionic liquid intermediates by reacting an alkali metal tetrafluoroborate with analkali metal cyanide in a solid state reaction; reacting preferably the potassium salt with an ammonium salt of pyridinium, imidazolium; chemical resistance; low viscosity; waterproofing; storage stability
01/12/2010CA2442906C Reconstitutable parenteral composition containing a cox-2 inhibitor
01/12/2010CA2411418C Hydroxyformamidine derivatives and medicines containing the same
01/12/2010CA2407463C N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
01/12/2010CA2346010C Derivatives of isosorbide mononitrate and its use as vasodilating agents with reduced tolerance
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
01/07/2010WO2010002577A1 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
01/07/2010WO2010001379A1 A process for preparing atovaquone and associate intermediates
01/07/2010WO2010001378A1 Process for the epimerization of atovaquone isomer, atovaquone intermediates and mixture thereof
01/07/2010WO2010000856A1 Method for producing aminobiphenylene
01/07/2010WO2010000673A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases
01/07/2010WO2010000008A1 Thiosemicarbazone compounds and use thereof
01/07/2010WO2009115517A3 Pyridines and pyrazines as inhibitors of pi3k
01/07/2010US20100004470 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
01/07/2010US20100004459 2-phenylnicotinic acid derivative
01/07/2010US20100004457 Process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
01/07/2010US20100004454 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives
01/07/2010US20100004438 Diarylether derivatives as antitumor agents
01/07/2010US20100004297 Novel hexafluoroisopropanol derivatives
01/07/2010US20100004295 Hydrazine amide derivative
01/07/2010US20100004290 Insecticidal n-substituted (heteroaryl)cycloalkyl sulfoximines
01/07/2010US20100004241 Non-imidazole aryloxyalkylamines
01/07/2010US20100004229 Potassium Channel Inhibitors
01/07/2010US20100001635 Novel organic electroluminescent compounds and organic electroluminescent device using the same
01/07/2010CA2764739A1 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases
01/07/2010CA2729697A1 Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines
01/07/2010CA2728469A1 Fungicide hydroximoyl-tetrazole derivatives
01/07/2010CA2728223A1 Method for producing aminobiphenyls
01/06/2010EP2141149A1 Process for producing substituted methylamine compound and triazine derivative
01/06/2010EP2139859A1 Dechalcogenative methods for the preparation of allylic sulfides
01/06/2010EP1562911B1 Compositions useful as inhibitors of jak and other protein kinases
01/06/2010CN101622231A 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
01/06/2010CN101619037A Polyphenyl substituted alpha active pyridinium compound and preparation method thereof
01/06/2010CN100577646C Method for preparing trifluoro methylpyridine compounds
01/06/2010CN100577645C Method for preparing 2,3-dichloro-5-trichloromethylpyridine
01/06/2010CN100577644C Preparation method for improving yield of gamma-(p-formaldehyde styryl) pyridine
01/06/2010CN100577642C Aluminium and copper metallized insulated material
01/06/2010CN100577633C CaSR antagonist
01/06/2010CN100577631C Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA-damaging treatments
01/06/2010CN100577286C Titanium-based catalyst for synthesizing pyridine base with formaldehyde, acetaldehyde and ammonia, as well as preparation method thereof
01/06/2010CN100577163C Compounds effecting glucokinase
01/05/2010US7642367 Diamino-functional chalcones
01/05/2010US7642280 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
01/05/2010US7642272 Cannabinoid receptor ligands
01/05/2010CA2545999C 1,2-di(cyclic)substituted benzene compounds
01/05/2010CA2318192C .beta.2-adrenergic receptor agonists
12/2009
12/31/2009US20090326235 Solutions of anhydrous lanthanide salts and its preparation
12/31/2009US20090326234 (S)-(-)-Amlodipine Camsylate or Hydrate Thereof And Pharmaceutical Composition Comprising Same
12/31/2009US20090326229 Alpha-carboline derivatives and methods for preparation thereof
12/31/2009US20090326222 Benzothiazole cyclobutyl amine derivatives
12/31/2009US20090325962 Tyrosine derivative
12/31/2009US20090325228 Fungal cell wall synthesis gene
12/31/2009US20090324569 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
12/31/2009US20090324540 Compounds and compositions for delivering active agents
12/31/2009US20090323508 Photosensitized composite material, three-dimensional memory material and recording medium, optical power limiting material and element, and photocuring material and stereolithography system, and fluorescent material for multiphoton fluorescence microscope and multiphoton fluorescence microscope
12/30/2009WO2009158026A1 Hydrazonamide compounds that modulate hsp90 activity
12/30/2009WO2009158011A1 Alkynyl alcohols as kinase inhibitors
12/30/2009WO2009157399A1 Sulfonamide compound or salt thereof
12/30/2009WO2009157196A1 Amide compound
12/30/2009WO2009156889A1 Diaryl compounds and uses thereof
12/30/2009WO2009156484A2 Organic compounds
12/30/2009WO2009156421A1 Squaric acid derivatives as inhibitors of the nicotinamide
12/30/2009WO2009156336A1 Sulfoximinamide compounds for combating animal pests
12/30/2009WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
12/30/2009EP2137154A2 Pyridine compounds for liquid-crystalline mixtures
12/30/2009EP2137153A1 Method for the hydrolysis of heteroaromatic nitriles in aqueous fluids
12/30/2009EP2136809A2 Raf kinase inhibitors containing a zinc binding moiety
12/30/2009EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
12/30/2009EP1911776B1 Polyacrylamide gel for electrophoresis, polyacrylamide gel electrophoresis method using the same, method of producing the same and acrylamide compound